{"id":198201,"date":"2024-10-19T12:37:02","date_gmt":"2024-10-19T12:37:02","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/aami-tir80001-2-3-2012\/"},"modified":"2024-10-25T05:10:12","modified_gmt":"2024-10-25T05:10:12","slug":"aami-tir80001-2-3-2012","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/aami\/aami-tir80001-2-3-2012\/","title":{"rendered":"AAMI TIR80001 2 3 2012"},"content":{"rendered":"
Supports the Healthcare Delivery Organizations (HDO) in the risk management of medical ITnetworks that incorporate one or more wireless links<\/p>\n
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
1<\/td>\n | ANSI\/AAMI\/IEC TIR80001-2-3:2012, Application of risk management for IT-networks incorporating medical devices \u2014 Part 2-3: Guidance for wireless networks <\/td>\n<\/tr>\n | ||||||
3<\/td>\n | Title Page <\/td>\n<\/tr>\n | ||||||
4<\/td>\n | Copyright <\/td>\n<\/tr>\n | ||||||
5<\/td>\n | AAMI Technical Information Report ANSI Technical Report <\/td>\n<\/tr>\n | ||||||
6<\/td>\n | Contents <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | Glossary of equivalent standards <\/td>\n<\/tr>\n | ||||||
12<\/td>\n | Committee representation <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | Background of ANSI\/AAMI adoption of IEC\/TR 80001-2-3:2012 <\/td>\n<\/tr>\n | ||||||
14<\/td>\n | FOREWORD <\/td>\n<\/tr>\n | ||||||
16<\/td>\n | INTRODUCTION <\/td>\n<\/tr>\n | ||||||
19<\/td>\n | 1 Scope and object 1.1 Scope 1.2 Objective <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | 1.3 HDO scalability 2 Normative references <\/td>\n<\/tr>\n | ||||||
21<\/td>\n | 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
31<\/td>\n | 4 Wireless medical IT-network: An introduction 4.1 Basics <\/td>\n<\/tr>\n | ||||||
32<\/td>\n | 4.2 Enterprise medical IT-network 4.3 Use of VLANs and SSIDs <\/td>\n<\/tr>\n | ||||||
33<\/td>\n | 4.4 Wide area medical IT-network <\/td>\n<\/tr>\n | ||||||
34<\/td>\n | 4.5 Smart phone applications 4.5.1 General 4.5.2 Application clinical functionality 4.5.3 Cellular networks <\/td>\n<\/tr>\n | ||||||
35<\/td>\n | 4.5.4 Smart phone coexistence 4.5.5 Wireless data security 4.6 Distributed antenna systems <\/td>\n<\/tr>\n | ||||||
36<\/td>\n | 5 Wireless medical IT-networks: Planning and design 5.1 Clinical systems and their impact on the wireless network 5.1.1 Defining the clinical SLA 5.1.2 Creating partnerships 5.1.3 Geographical location <\/td>\n<\/tr>\n | ||||||
37<\/td>\n | 5.1.4 Clinical use case 5.2 Medical device wireless capabilities 5.3 Medical device capabilities and networking traffic profile 5.4 Network performance requirements <\/td>\n<\/tr>\n | ||||||
38<\/td>\n | 5.5 QoS mechanisms 5.6 Receiver capabilities <\/td>\n<\/tr>\n | ||||||
39<\/td>\n | 5.7 Received signal strength and SNR versus data rates <\/td>\n<\/tr>\n | ||||||
40<\/td>\n | 5.8 Capacity versus coverage versus AP density <\/td>\n<\/tr>\n | ||||||
41<\/td>\n | 5.9 Deterministic versus non-deterministic wireless access protocol 5.10 Planning and design summary 6 Wireless medical IT-networks: Deployment and configuration 6.1 Risks versus benefit of a wireless communications system <\/td>\n<\/tr>\n | ||||||
42<\/td>\n | 6.2 Licensed versus unlicensed spectrum 6.3 Interference sources 6.4 Spectrum usage and allocation 6.4.1 Device coexistence 6.4.2 Spectrum management <\/td>\n<\/tr>\n | ||||||
43<\/td>\n | 6.4.3 Capacity management 6.5 Wireless network configuration (802.11 specific) 6.5.1 General 6.5.2 VLAN and SSID <\/td>\n<\/tr>\n | ||||||
44<\/td>\n | 6.5.3 Authentication and encryption 6.5.4 Vendor proprietary extensions 6.5.5 Cellular and proprietary networks <\/td>\n<\/tr>\n | ||||||
45<\/td>\n | 6.5.6 Network availability 6.6 Verification testing 6.6.1 General 6.6.2 Pre go-live verification testing 6.6.3 Go-live verification testing <\/td>\n<\/tr>\n | ||||||
46<\/td>\n | 7 Wireless medical IT-networks: Management and support 7.1 General 7.2 Network and application management 7.3 Policies and procedures <\/td>\n<\/tr>\n | ||||||
47<\/td>\n | 7.4 Change control 8 General risk control measures 8.1 General 8.2 Determining baseline networking performance <\/td>\n<\/tr>\n | ||||||
48<\/td>\n | 8.3 Designing for coverage signal strength 8.4 Segregating traffic and data types 8.5 Environmental and physical changes 8.6 Maintaining a clean RF environment <\/td>\n<\/tr>\n | ||||||
49<\/td>\n | 8.7 Capacity planning 8.7.1 General 8.7.2 5 GHz and dynamic frequency selection (DFS) 8.7.3 Security measures and planning <\/td>\n<\/tr>\n | ||||||
50<\/td>\n | 8.8 RF spectrum use 8.9 Device and application classification <\/td>\n<\/tr>\n | ||||||
51<\/td>\n | 8.10 Guest or smart phone access 8.11 WLAN infrastructure configuration 8.12 External partnering with both medical device and networking manufacturer 8.13 Redundancy <\/td>\n<\/tr>\n | ||||||
53<\/td>\n | Annex A (informative) Clinical use cases and network traffic profiles <\/td>\n<\/tr>\n | ||||||
55<\/td>\n | Annex B (informative) Questions to consider <\/td>\n<\/tr>\n | ||||||
60<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" AAMI\/IEC TIR80001-2-3:2012 – Application of risk management for IT-networks incorporating medical devices-Part 2-3: Guidance for wireless networks<\/b><\/p>\n |